Arkolith/Insider Trading/TLIS/Form 4

Scott Randal W.

DirectorTalis Biomedical Corp (TLIS) · full profile →Form 4 · filed May 18, 2021
Net Buying
Open-Market Buys
$203K
Open-Market Sells
$0
Net Open-Market Flow
$203K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 17, 2021Buy(P)11K$10.11$111K20K
May 14, 2021Buy(P)9K$10.16$91K9K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-033441) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML